Product NDC: | 0703-5145 |
Proprietary Name: | Leucovorin Calcium |
Non Proprietary Name: | Leucovorin Calcium |
Active Ingredient(s): | 350 mg/17.5mL & nbsp; Leucovorin Calcium |
Administration Route(s): | INTRAMUSCULAR; INTRAVENOUS |
Dosage Form(s): | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Coding System: | National Drug Codes(NDC) |
Product NDC: | 0703-5145 |
Labeler Name: | Teva Parenteral Medicines, Inc. |
Product Type: | HUMAN PRESCRIPTION DRUG |
FDA Application Number: | ANDA040174 |
Marketing Category: | ANDA |
Start Marketing Date: | 19970612 |
Package NDC: | 0703-5145-01 |
Package Description: | 1 VIAL, SINGLE-USE in 1 CARTON (0703-5145-01) > 17.5 mL in 1 VIAL, SINGLE-USE |
NDC Code | 0703-5145-01 |
Proprietary Name | Leucovorin Calcium |
Package Description | 1 VIAL, SINGLE-USE in 1 CARTON (0703-5145-01) > 17.5 mL in 1 VIAL, SINGLE-USE |
Product NDC | 0703-5145 |
Product Type Name | HUMAN PRESCRIPTION DRUG |
Non Proprietary Name | Leucovorin Calcium |
Dosage Form Name | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION |
Route Name | INTRAMUSCULAR; INTRAVENOUS |
Start Marketing Date | 19970612 |
Marketing Category Name | ANDA |
Labeler Name | Teva Parenteral Medicines, Inc. |
Substance Name | LEUCOVORIN CALCIUM |
Strength Number | 350 |
Strength Unit | mg/17.5mL |
Pharmaceutical Classes | Folate Analog [EPC],Folic Acid [Chemical/Ingredient] |